Clinical Trial Update: PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial status update for a PD-1 inhibitor combined with chemotherapy and PULSAR in locally advanced and recurrent pancreatic cancer; currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• PD-1 inhibitor
• PULSAR

Snippet

Sponsor: Fudan University | Conditions: Pancreatic Cancer | Phase 2 | Status: RECRUITING